Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Prostaglandin D₂ might be targeted for new male pattern baldness treatments.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

Metformin may help regulate periods and cause modest weight loss in PCOS patients, but more research is needed.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

Rats had lasting erectile problems after stopping a certain medication.

The treatment led to denser, thicker hair growth and less hair loss.

Low estrogen compared to androgen may cause female hair loss.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Bald men may have a lower risk of testicular cancer.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Higher DHT in male baldness may protect against prostate cancer.

Hidradenitis suppurativa improves with antiandrogen therapy.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Higher testosterone and DHT levels are linked to hair loss in men, but not to prostate cancer risk.

Acupuncture may improve reproductive and metabolic functions in PCOS without negative side effects, but more research is needed to confirm its effectiveness.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.